JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Cervical mucus can be used for metabolite screening in cervical cancer

  • 0Department of Gynecology, School of Medicine, Fujita Health University, Toyoake, Japan.
Cancer Science +

|

August 22, 2024

|

August 22, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Metabolomic analysis of cervical mucus identified new biomarkers for cervical cancer and precancerous lesions. This approach may improve early detection and understanding of cervical neoplasia development.

Area Of Science

  • Biochemistry
  • Oncology
  • Metabolomics

Background

  • Cervical cancer affects approximately 660,000 women annually.
  • Current screening methods like cytology and HPV testing have limitations.
  • There is a need for effective ancillary biomarkers for improved triage.

Purpose Of The Study

  • To evaluate metabolomic analysis of cervical mucus for identifying biomarkers of cervical intraepithelial neoplasia (CIN) and cervical cancer.
  • To explore metabolic pathways associated with cervical neoplasia.

Main Methods

  • Case-control study with 181 CIN, 69 squamous cell carcinoma (SCC) patients, and 48 healthy controls.
  • Metabolomic analysis using ultra-high-performance liquid chromatography-tandem mass spectrometry (UHPLC-MS/MS).
  • Univariate, multivariate, and receiver operating characteristic (ROC) analyses for biomarker identification.

Main Results

  • Five metabolites showed high discriminatory power for SCC: oxidized glutathione (GSSG), malic acid, kynurenine, GSSG/glutathione (GSH), and kynurenine/tryptophan.
  • Malic acid was the best marker for detecting CIN2 or worse.
  • Metabolomic analysis identified eight pathways linked to cervical neoplasia, including the tricarboxylic acid cycle and altered arginine metabolism.

Conclusions

  • Metabolic analysis of cervical mucus can identify promising ancillary biomarkers for cervical cancer and precancer.
  • These findings enhance understanding of the pathophysiological mechanisms driving cervical neoplasia.
  • Further research may lead to improved diagnostic and prognostic tools for cervical cancer.

Keywords: